Declines in mortality from acute myocardial infarction in successive incidence and birth cohorts of patients with rheumatoid arthritis

Circulation

Volumn 110, Issue 13, 2004, Pages 1774-1779

  Krishnan, Eswar ^a   Lingala, Vijaya Bharathi ^a   Singh, Gurkirpal ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

Mortality; Myocardial infarction; Rheumatoid arthritis; Risk; Trend

Indexed keywords

METHOTREXATE; PREDNISONE;

ACUTE HEART INFARCTION; ADULT; AGE; AGED; ARTICLE; CONTROLLED STUDY; DISEASE DURATION; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL; RACE DIFFERENCE; RHEUMATOID ARTHRITIS; SEX DIFFERENCE;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS; ARTHRITIS, RHEUMATOID; CASE MANAGEMENT; COHORT STUDIES; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; MALE; METHOTREXATE; MIDDLE AGED; MORTALITY; MYOCARDIAL INFARCTION; NORTH AMERICA; OUTCOME ASSESSMENT (HEALTH CARE); PREDNISONE; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RISK;

EID: 4644220794     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000142864.83780.81     Document Type: Article

References (40)

1. Wilske KR, Healey LA. Remodeling the pyramid: a concept whose time has come. J Rheumatol. 1989;16:565-567.
2. Wolfe F, Mitchell DM, Sibley JT, et al. The mortality of rheumatoid arthritis. Arthritis Rheum. 1994;37:481-494.
3. Krishnan E, Fries JF. Reduction in long-term functional disability in rheumatoid arthritis from 1977-1988: a longitudinal study of 3035 patients. Am J Med. 2003;115:371-376.
4. Ward MM. Trends in the use of disease modifying antirheumatic medications in rheumatoid arthritis, 1980-1995: results from the National Ambulatory Medical Care Surveys. J Rheumatol. 1999;26:546-550.
5. Sattar N, McCarey DW, Capell H, et al. Explaining how "high-grade" systemic inflammation accelerates vascular risk in rheumatoid arthritis. Circulation. 2003;108:2957-2963.
6. Lindqvist E, Eberhardt K. Mortality in rheumatoid arthritis patients with disease onset in the 1980s. Ann Rheum Dis. 1999;58:11-14.
7. Decline in deaths from heart disease and stroke: United States, 1900-1999. MMWR Morb Mortal Wkly Rep. 1999;48:649-656.
8. Krishnan E, Singh G, Tugwell P. Long-term observational studies. In: Smolen J, Lipsky P, eds. Targeted Therapies in Rheumatology. London: Martin Dunitz; 2003.
9. Singh G. Arthritis, Rheumatism and Aging Medical Information System Post-Marketing Surveillance Program. J Rheumatol. 2001;28:1174-1179.
10. Ropes MB, Cobb GA, Jacox S, et al. 1958 revision of diagnostic criteria for rheumatoid arthritis. Bull Rheum Dis. 1958;9:175-176.
11. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315-324.
12. The National Death Index (NDI). In: National Center for Health Statistics. Available from http://www.cdc.gov/nchs/r&d/ndi.htm. Accessed on February 22, 2002.
13. Moeschberger ML, Klein JP. Statistical methods for dependent competing risks. Lifetime Data Anal. 1995;1:195-204.
14. Statacorp. STRATE. In: Stata Reference Manual. 7.0 ed. College Station, Tex: Stata Press; 1999:424-431.
15. Clayton D, Hills M. Statistical Models in Epidemiology. Oxford, UK: Oxford University Press; 1993.
16. Kent J. Robust properties of likelihood ratio tests. Biometrika. 1982;69:19-27.
17. Mutru O, Laakso M, Isomaki H, et al. Cardiovascular mortality in patients with rheumatoid arthritis. Cardiology. 1989;76:71-77.
18. Mutru O, Laakso M, Isomaki H, et al. Ten year mortality and causes of death in patients with rheumatoid arthritis. BMJ (Clin Res Ed). 1985;290:1797-1799.
19. Solomon DH, Karlson EW, Rimm EB, et al. Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation. 2003;107:1303-1307.
20. del Rincon ID, Williams K, Stern MP, et al. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum. 2001;44:2737-2745.
21. Kvalvik AG, Jones MA, Symmons DP. Mortality in a cohort of Norwegian patients with rheumatoid arthritis followed from 1977 to 1992. Scand J Rheumatol. 2000;29:29-37.
22. Koota K, Isomaki H, Mutru O. Death rate and causes of death in RA patients during a period of five years. Scand J Rheumatol. 1977;6:241-244.
23. Wolfe F, Freundlich B, Straus WL. Increase in cardiovascular and cerebrovascular disease prevalence in rheumatoid arthritis. J Rheumatol. 2003;30:36-40.
24. Cobb S, Anderson F, Bauer W. Length of life and cause of death in rheumatoid arthritis. N Engl J Med. 1953;249:553-556.
25. Davies R, Eg E. Incidence of myocardial infarction in patients with rheumatoid arthritis. Arthritis Rheum. 1974;17:527-533.
26. Cathcart E, Spodick D. Rheumatoid heart disease: a study of the incidence and nature of cardiac lesions in rheumatoid arthritis. J Med. 1962;266:959-964.
27. Pincus T, Sokka T, Wolfe F. Premature mortality in patients with rheumatoid arthritis: evolving concepts. Arthritis Rheum. 2001;44:1234-1236.
28. Linos A, Worthington JW, O'Fallon WM, et al. The epidemiology of rheumatoid arthritis in Rochester, Minnesota: a study of incidence, prevalence, and mortality. Am J Epidemiol. 1980;111:87-98.
29. Wallberg-Jonsson S, Ohman ML, Dahlqvist SR. Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in Northern Sweden. J Rheumatol. 1997;24:445-451.
30. Bjornadal L, Baecklund E, Yin L, et al. Decreasing mortality in patients with rheumatoid arthritis: results from a large population based cohort in Sweden, 1964-95. J Rheumatol. 2002;29:906-912.
31. Doran MF, Pond GR, Crowson CS, et al. Trends in incidence and mortality in rheumatoid arthritis in Rochester, Minnesota, over a forty-year period. Arthritis Rheum. 2002;46:625-631.
32. Mulvihill NT, Foley JB. Inflammation in acute coronary syndromes. Heart. 2002;87:201-204.
33. Pasceri V, Willerson JT, Yeh ET. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation. 2000;,102:2165-2168.
34. McEntegart A, Capell HA, Creran D, et al. Cardiovascular risk factors, including thrombotic variables, in a population with rheumatoid arthritis. Rheumatology. 2001;40:640-644.
35. Singh G, Miller JD, Huse DM, et al. Consequences of increased systolic blood pressure in patients with osteoarthritis and rheumatoid arthritis. J Rheumatol. 2003;30:714-719.
36. Park YB, Choi HK, Kim MY, et al. Effects of antirheumatic therapy on serum lipid levels in patients with rheumatoid arthritis: a prospective study. Am J Med. 2002;113:188-193.
37. Choi HK, Hernan MA, Seeger JD, et al. Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study. Lancet. 2002;359:1173-1177.
38. Van Doomum S, McColl G, Wicks IP. Accelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis? Arthritis Rheum. 2002;46:862-873.
39. Morrison C, Woodward M, Leslie W, et al. Effect of socioeconomic group on incidence of, management of, and survival after myocardial infarction and coronary death: analysis of community coronary event register. BMJ. 1997;314:541-546.
40. Krishnan E. Access to medical care in rheumatoid arthritis patients: a population survey of seven states in the USA. Arthritis Rheum. 2002;44:318. Abstract.